Trial Information

Summary: If you have been diagnosed with Interstitial Cystitis (painful bladder syndrome) and are experiencing symptoms of pain and or pressure in the bladder area and urinary frequency and urgency, you may qualify to participate in our research study.

We are currently conducting a research study evaluating the safety and effectiveness of an investigational drug for the treatment of pain due to Interstitial Cystitis.

You may be eligible to participate if you:

  • are a male or female 18 years or older.
  • have moderate to severe pain, pressure or discomfort due to painful bladder syndrome for at least 6 months.

All study-related evaluations, laboratory test, and investigational drug will be provided at no cost to you. You may also be compensated for time and travel.

Contact:

Sarah Weese, Financial Coordinator
Integrity Medical Research, LLC
6005 244th St., SW #121
Mountlake Terrace, WA 98043
Telephone: 425-275-0680
Fax: 425-275-0681
Email:

Profile Page: Integrity Medical Research, LLC, Mountlake Terrace, WA

If you would like to learn more about participating in this study, please send an e-mail message using the form below.

*Subject:

Name:

Address:

City:

State:

*Zip:

*Country:

Phone:

*Email address:

Message:


Please note: A number of commercial online services display an error message after you click on Send. Please be assured that your message has been received.

This site is run by CenterWatch, a publishing company that focuses on the clinical trials industry. The information provided in this service is designed to help patients find clinical trials that may be of interest to them, and to help patients contact the centers conducting the research. CenterWatch is neither promoting this research nor involved in conducting any of these trials.

Trial listings updated: June 24, 2008 at 4:48:29 PM


Back to Centerwatch Trial Listing by Location


Additional resources
in this illness area

Copyright © 1995 - 2008, CenterWatch
All Rights Reserved

This site was developed in association with Illumina Interactive, Boston, MA